Safe-T Group (NASDAQ:SFET) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.60) by 88.33 percent. This is a 93.64 percent increase over losses of $(1.10) per share from the same period last year. The company reported quarterly sales of $4.81 million which beat the analyst consensus estimate of $4.75 million by 1.31 percent. This is a 42.49 percent increase over sales of $3.38 million the same period last year.
Natera Files Patent Infringement Suit Against NeoGenomics Labs For Infringement Of Natera’s U.S. Patent Numbers. 11,519,035 And 11,530,454 By Neogenomics’ Radar Molecular Residual Disease Assay
Natera, Inc. (NASDAQ:NTRA), a global leader in cell-free DNA testing, today announced that it has filed a lawsuit in the North Carolina Federal District Court against NeoGenomics Labs, Inc. ("NeoGenomics")